Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore Karrison

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Biometrics|June 20, 2025
Non-parametric estimators of hazard ratios for comparing two survival curvesMihai Giurcanu, Theodore Karrison
Statistics in Medicine|December 14, 2006
Continuous Bayesian adaptive randomization based on event times with covariates by Cheung et al., Statistics in Medicine 2006; 25:55-70Rick Chappell, Theodore Karrison
Clinical Trials (London, England)|March 6, 2018
Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?Theodore Karrison, Masha Kocherginsky
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
Troxacitabine in patients with refractory leukemiaTheodore Karrison, Mark Ratain
Clinical Trials (London, England)|June 14, 2024
Scaling and interpreting treatment effects in clinical trials using restricted mean survival timeTheodore Karrison, Chen Hu, James Dignam
Journal of Neurosurgery|January 17, 2002
Sizes of ruptured and unruptured aneurysms in relation to their sites and the ages of patientsBryce Weir, Lew Disney, Theodore Karrison
Anesthesiology|May 13, 2025
Cardiac Events after Electroconvulsive Therapy: ReplyAndreas Duma, Theodore Karrison, Peter Nagele
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 2, 2008
Modeling major lung resection outcomes using classification trees and multiple imputation techniquesMark K Ferguson, Juned Siddique, Theodore Karrison
Journal of Biopharmaceutical Statistics|April 23, 2009
Design of Phase II cancer trials for evaluation of cytostatic/cytotoxic agentsMasha Kocherginsky, Ezra E W Cohen, Theodore Karrison
Clinical Genitourinary Cancer|July 22, 2022
Evaluation of Provider Preferences in First-Line Metastatic Renal Cell Carcinoma: Comparison Between Dual Immunotherapy vs. Immunotherapy/Tyrosine Kinase InhibitorsPriyanka V Chablani, Theodore Karrison, Walter M Stadler
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Biometrics|June 20, 2025
Non-parametric estimators of hazard ratios for comparing two survival curvesMihai Giurcanu, Theodore Karrison
Statistics in Medicine|December 14, 2006
Continuous Bayesian adaptive randomization based on event times with covariates by Cheung et al., Statistics in Medicine 2006; 25:55-70Rick Chappell, Theodore Karrison
Clinical Trials (London, England)|March 6, 2018
Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?Theodore Karrison, Masha Kocherginsky
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
Troxacitabine in patients with refractory leukemiaTheodore Karrison, Mark Ratain
Clinical Trials (London, England)|June 14, 2024
Scaling and interpreting treatment effects in clinical trials using restricted mean survival timeTheodore Karrison, Chen Hu, James Dignam
Journal of Neurosurgery|January 17, 2002
Sizes of ruptured and unruptured aneurysms in relation to their sites and the ages of patientsBryce Weir, Lew Disney, Theodore Karrison
Anesthesiology|May 13, 2025
Cardiac Events after Electroconvulsive Therapy: ReplyAndreas Duma, Theodore Karrison, Peter Nagele
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 2, 2008
Modeling major lung resection outcomes using classification trees and multiple imputation techniquesMark K Ferguson, Juned Siddique, Theodore Karrison
Journal of Biopharmaceutical Statistics|April 23, 2009
Design of Phase II cancer trials for evaluation of cytostatic/cytotoxic agentsMasha Kocherginsky, Ezra E W Cohen, Theodore Karrison
Clinical Genitourinary Cancer|July 22, 2022
Evaluation of Provider Preferences in First-Line Metastatic Renal Cell Carcinoma: Comparison Between Dual Immunotherapy vs. Immunotherapy/Tyrosine Kinase InhibitorsPriyanka V Chablani, Theodore Karrison, Walter M Stadler
Pageof 16